|Articles|June 1, 2008

Pharmaceutical Executive

  • Pharmaceutical Executive-06-01-2008
  • Volume 0
  • Issue 0

Roger Adsett, Shire

S

Roger Adsett

VP and General Manager, Gastroenterology, Shire

NOTED FOR: Strong leadership, building blockbuster brands

VISION: "Explain it so others internalize—not recite—it"

Roger Adsett knows big brands. He cut his teeth at Astra Merck, heading up marketing for Nexium, then moved to England to serve as global brand director for AstraZenica's Symbicort. Now re-settled in the Northeast corridor, he's translating marketing savvy and global know-how to Shire's GI business—with good results. Last year's launch of Lialda sent business soaring, without cannibalizing Pentasa sales. Shire brands now serve more than a quarter of the oral mesalamine market. And with a co-promotion deal signed with TAP, Adsett will bring his blockbuster mindset to the realm of specialty sales.

Roger Adsett

Articles in this issue

almost 18 years ago

Mary Szela, Abbott

almost 18 years ago

Mightier Than the Sword

almost 18 years ago

Eric Floyd, Cephalon

almost 18 years ago

Nancy Phelan, Wyeth

almost 18 years ago

Tightening the Chain

almost 18 years ago

Kurt Graves, Vertex

almost 18 years ago

Wendy Niebler, Shire

almost 18 years ago

Perfectly Imperfect

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.